NEW YORK–(BUSINESS WIRE)–Ophthotech announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present at the UBS Global Healthcare Conference in New York City on Monday, May 18, 2015.
Eleven Biotherapeutics reports net loss of $6.5 million in first quarter
Eleven Biotherapeutics reported a net loss applicable to common stockholders of $6.5 million, or $0.36 per share, in the first quarter of 2015, compared with a net loss of $7.7 million, or $0.80 per share, in the first quarter of 2014, according to a p…
VIDEO: Speaker gives overview of past and present of refractive surgery
PARIS — At the meeting of the French Society of Ophthalmology, Béatrice Cochener, MD, PhD, talks about the past and present of refractive surgery. Science progresses through trial and error, and the weak points of new techniques should be viewed as obstacles to overcome in order to go further.
Isarna presents positive preclinical results supporting development of ISTH0036 for the treatment of glaucoma
Isarna Therapeutics, the leader in transforming growth factor beta (TGF-ß) isoform targeted antisense therapeutics, today announced the presentation of preclinical data for its lead candidate…
Smart micro chips may optimise human vision
To date, chip-based retinal implants have only permitted a rudimentary restoration of vision. However, modifying the electrical signals emitted by the implants could change that.
New study finds short-sightedness is becoming more common across Europe
Myopia or short-sightedness is becoming more common across Europe, according to a new study led by King’s College London.